Levi Strauss (NYSE:LEVI) Stock

LEVI STRAUSS & CO- CLASS A

Levi Strauss

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Levi Strauss & Co

LEVIATHAN GOLD LTD by Leviathan Gold Ltd.

Leviathan Gold Ltd

Leviathan Gold Ltd Ordinary Shares

Levitee Labs Inc

Golar LNG Limited (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLNG#NASDAQ">GLNG</a>) announces today that it intends to offer, subject to market and other conditions, $500 million aggregate principal amount of Convertible Senior Notes due 2030 (the "Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant the initial purchasers of the Notes a 30-day option to purchase up to an additional $75 million aggregate principal amount of the Notes in connection with the offering.

News

Offerings

GLNG

Intends To Offer $500M Aggregate Principal Amount Of Convertible Senior Notes Due 2030

Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.82 by 27.27 percent. This is a 0.94 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $832.900 million which beat the analyst consensus estimate of $800.450 million by 4.05 percent. This is a 8.57 percent decrease over sales of $911.000 million the same period last year.

Earnings

Earnings Beats

Worthington Steel Q4 Adj. EPS $1.05 Beats $0.82 Estimate, Sales $832.900M Beat $800.450M Estimate

Earnings Misses

Jefferies Financial Gr Q2 Adj. EPS $0.40 Misses $0.44 Estimate, Sales $1.63B Beat $1.56B Estimate

Guidance

CULP

Culper Says 'Due to macro-economic uncertainty and the fluid tariff environment, the Company is not providing specific financial guidance, but only limited annual guidance at this time.'; Sees YoY Sales Growth In Mattress Fabrics Business And For Sales Pressure On Residential Side Of Upholstery Business To Continue

Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 56.41 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $48.773 million which missed the analyst consensus estimate of $52.400 million by 6.92 percent. This is a 1.52 percent decrease over sales of $49.528 million the same period last year.

Culp Q4 EPS $(0.17) Misses $(0.14) Estimate, Sales $48.773M Miss $52.400M Estimate

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
<ul>
<li>First subject screened at the Respiratory Medicine Research Institute of Michigan with Dr. Jeffrey Leflein acting as Principal Investigator</li>
<li>Additional sites, including Allergy and Asthma Center of Minnesota and Hamilton Allergy and Immunology Clinic of Ontario, Canada have been activated and are scheduling screenings</li>
</ul>
DBV Technologies (TRQX:<a href="https://www.benzinga.com/stock/DBVp#TRQX">DBVp</a>), a clinical-stage biopharmaceutical company, today provided an update on the progress on the Company's COMFORT Toddlers supplemental safety study using the Viaskin&#xAE; Peanut patch 250 μg in peanut-allergic children ages 1 – 3 years old.
COMFORT Toddlers will enroll approximately 480 subjects at approximately 80 – 90 study centers across the U.S., Canada, Australia, UK and Europe. Principal Investigator, Jeffrey Leflein, MD, FAAAAI, FACAAI from the Respiratory Medicine Research Institute of Michigan, in Ann Arbor, Michigan screened the first subject in the study. Additionally, Dr. Doug McMahon, MD, Allergy and Asthma Center in Maplewood, Minnesota and Dr. Jason Ohayon, MD, Hamilton Allergy and Immunology Clinic in Ontario, Canada have been activated and are currently open to recruitment.
"I am thrilled that our talented team of clinicians was the first to screen a subject for the COMFORT Toddlers supplemental safety study and we have several other potential subjects scheduled for screening," said Dr. Leflein. "The initiation of subject enrollment in COMFORT Toddlers reinforces our commitment to peanut-allergic children and their families and is an important step in generating the data needed to potentially advance the Viaskin Peanut patch to market."
COMFORT Toddlers is a Phase 3 double-blind, placebo-controlled (DBPC) safety study designed to supplement the safety and efficacy data from the completed Phase 3 EPITOPE study in the same population. The study duration will be six months followed by an optional 18-month open-label treatment phase, to generate up to 24 or 18 months of active treatment with the Viaskin Peanut patch for participants randomized to the active or placebo groups, respectively.
"I am very pleased subject screening has commenced in COMFORT Toddlers and look forward to working with my fellow investigators on the efficient enrollment and execution of this important study,"&nbsp;stated Julie Wang, MD, FAAAAI, FACAAI, Professor of Pediatrics, Jaffe Food Allergy Institute, the Icahn School of Medicine at Mount Sinai and Global Principal Investigator for the COMFORT Toddlers study.&nbsp;"The interest we've seen to date further reinforces the significant unmet need that exists for this specific subject cohort."
"Screening our first subject marks a crucial step forward in our mission to develop this potential groundbreaking therapy for food allergic patients, as we are now well underway with both of our core clinical programs," said Daniel Tassé CEO, DBV Technologies. "We believe the data generated through the COMFORT Toddlers study will complete the data set necessary for a Biologics License Application submission to the FDA. DBV is committed to advancing the development of Viaskin Peanut. Our patients and their families are counting on us."

Biotech

General

DBVT

DBV Technologies Announces It Has Screened The First Subject In COMFORT Toddlers Supplemental Safety Study In Peanut Allergic Toddlers 1 – 3 Years Old

Management

TREX

Trex CFO Brenda Lovcik Resigns; Bryan Fairbanks Appointed Interim CFO

WIIM

BTBT

Bit Digital shares are trading lower after the company announced a public offering.

Linde (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>) has outperformed the market over the past 20 years by 3.78% on an annualized basis producing an average annual return of 12.2%. Currently, Linde has a market capitalization of $217.63 billion. 
Buying $1000 In LIN: If an investor had bought $1000 of LIN stock 20 years ago, it would be worth $9,941.67 today based on a price of $460.20 for LIN at the time of writing.
<h3>Linde's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750882533_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

H.B. Fuller shares are trading higher after the company raised its FY2025 Adj. EPS guidance.

MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.44 by 37.3 percent. This is a 10.45 percent decrease over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $961.80 million which beat the analyst consensus estimate of $913.70 million by 5.26 percent. This is a 8.20 percent increase over sales of $888.90 million the same period last year.

MLKN

MillerKnoll Q4 Adj. EPS $0.60 Beats $0.44 Estimate, Sales $961.80M Beat $913.70M Estimate

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1275158/000127515825000081/ndls-20250624.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1275158/000127515825000081/ndls-20250624.htm</a>

NDLS

Noodles & Co Receives Nasdaq Non-Compliance Notice

MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is looking for Q1 Adj EPS of $0.32-$0.38 vs $0.35 analyst estimate. sees sales of $899.000 million-$939.000 million vs $890.70 million analyst estimate.

MillerKnoll Sees Q1 Adj EPS $0.32-$0.38 vs $0.35 Est; Sees Sales $899.000M-$939.000M vs $890.70M Est

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

In March Bit Digital Held 24,434.2 ETH And 417.6 BTC Valued At $44.6M And $34.5M; Intends To Convert BTC Holdings Into ETH Over Time

Euroholdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHLD#NASDAQ">EHLD</a>) reported quarterly earnings of $0.31 per share. This is a 42.59 percent decrease over earnings of $0.54 per share from the same period last year. The company reported $2.873 million in sales this quarter. This is a 24.91 percent decrease over sales of $3.826 million the same period last year.

EHLD

Euroholdings Q1 Adj. EPS $0.31 Down From $0.54 YoY, Sales $2.873M Down From $3.826M YoY

GKOS

Glaukos Announces EU MDR Certification For iStent infinite

MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.44 by 37.3 percent. This is a 10.45 percent decrease over earnings of $0.67 per share from the same period last year.

MillerKnoll Q4 Adj. EPS $0.60 Beats $0.44 Estimate

H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) today reported financial results for its second quarter that ended May 31, 2025.
 Fiscal 2025 Outlook:
As a result of our strong financial performance, we are updating our previously communicated financial guidance for fiscal 2025 as follows:
<ul>
<li>Net revenue for fiscal 2025 is now expected to be down 2% to 3%; organic revenue for fiscal 2025 is still expected to be flat to up 2%; we now expect foreign exchange to adversely impact net revenue by 1.0% to 1.5%;</li>
<li>Adjusted EBITDA for fiscal 2025 is now expected to be in the range of $615 million to $630 million, equating to growth of 4% to 6% year-on-year;</li>
<li>Adjusted EPS (diluted) is now expected to be in the range of $4.10 to $4.30, equating to growth of 7% to 12% year-on-year;</li>
<li>Fully diluted shares outstanding for fiscal 2025 is now expected to be in the range of 55 million to 56 million;</li>
<li>Adjusted EBITDA for the third quarter of 2025 is expected to be in the range of $165 million to $175 million.</li>
</ul>

H.B. Fuller Now Expects FY25 Revenue To Be Down 2% - 3%; Now Sees FY25 Organic Revenue To Be Flat To Up 2%

ASAN

Asana Appoints Dan Rogers As CEO, Effective July 21, 2025

Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is looking for Q2 GAAP EPS of $0.27-$0.31 vs $0.39 analyst estimate..

Steelcase Sees Q2 GAAP EPS $0.27-$0.31 vs $0.39 Est

Press Releases

Levi Strauss & Co. Receives Ratings Upgrade from Fitch Ratings

Beyoncé and Levi's® Launch Chapter 2 with REIIMAGINE: Pool Hall

Levi Strauss & Co. Announces Participation in Upcoming Investor Conferences

Levi Strauss & Co. to Webcast First Quarter 2025 Earnings Conference Call

Levi Strauss & Co. Reports Better Than Expected First-Quarter 2025 Financial Results

Beyoncé and Levi's® Launch Chapter 3 with REIIMAGINE: Refrigerator

Levi Strauss & Co. Unveils Plans for 25 New Murals Across San Francisco

Levi Strauss & Co. Enters into Definitive Agreement to Sell Dockers® to Authentic Brands Group

Levi Strauss & Co. Announces Participation at the Deutsche Bank Global Consumer Conference

Comments

Levi Strauss

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL